1 prior line of therapy, No Maintenance, Phase 2, Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), Carfilzomib Maintenance
### Instruction:
Identify the study with the following condition. 
### Input:
1 prior line of therapy, No Maintenance, Phase 2, Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), Carfilzomib Maintenance 
### Output:
Popular Name is MUK Five, Study ID is ISRCTN17354232